John C.k. Milligan IV, President, Secretary at TherapeuticsMD, Inc. (TXMD), sold 25,000 shares at $5.94 ($154K) on 2014-01-28, disclosed to the SEC on 2014-01-30.
Scheduled sale ($154k) by President, Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.94 | 8,300 | $49K | 32.0% |
| 2 | $6.03 | 8,300 | $50K | 32.5% |
| 3 | $6.49 | 8,400 | $55K | 35.4% |
| Total | $6.15 avg | 25,000 | $154K | 100% |
| Filing → |
| TXMD | BUY | 2019-08-19 | $29K | — | Filing → |
| TXMD | BUY | 2019-08-14 | $47K | — | Filing → |
| TXMD | SELL | 2018-12-19 | $1.4M | — | Filing → |